HOW TO USE WIXELA INHUBWixela Inhubwas designed with patients in mind - PDF document

1 HOW TO USE WIXELA® INHUB®Wixela Inhubw
HOW TO USE WIXELA® INHUB®Wixela Inhubwas designed with patients in mind to help you make a seamless transition from ADVAIR DISKUS® (uticasone propionate and salmeterol inhalation powder).Take Wixela Inhub out of the foil pouch just before you use it for the rst time. Write the “Pouch opened” and “Use by” dates oThe “Use by” date is one month from the date you open the pouch for your rst dose. Follow the 5 steps below each time you take a dose. 1 •Hold the INHUB in the 4 doses00000000 Discard 1 month after propionate and do0000000Rxly ou openeUse Disc montaftovaro tefoi MDR:9320:60D:R-A78-9320-3 uicasoneropionate ansalmeterol inhalation powder, USP 100/ •Push the mouthpiece cover up to the closed•The dose counter will count down one dose as•The INHUB is now ready for you to take your doses0000000 Pouchopened:Use by:Discar 1 month afterremoval from the foil pouch. A-2R:D06:0239:RDMNDC0378--32 propionate and 50 •Before you breathe in your dose from the INHUB, breathe out (exhale) as long as you•Put the mouthpiece to your lips. Breathe in quickly and deeply through the INHUB.•The INHUB delivers your dose of medicine as a very fine powder that you may or may not taste WIXELA INHUB is a twice-daily prescription medicine used to control symptoms of asthma and to prevent symptoms such as wheezing in patients 4 years and older. WIXELA INHUB is for adults and children with asthma who are not well controlled with an asthma control medicine, such as an inhaled corticosteroid (ICS) medicine and need both an ICS and long-acting betaWIXELA INHUB 250/50 is a twice-daily prescription medicine used long term to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis, emphysema, or both, for better breathing and fewer flare-ups. Patient Information for full Instructions for Use. WIXELA and INHUB are registered trademarks of Mylan Pharmaceuticals Inc., a Viatris Company.ADVAIR DISKUS and SEREVENT are registered trademarks of the GSK group of companies. When using yourWixela® Inhub®please be aware of these important components MouthpieceDose counterMouthpiece coverYellow leverAir ventsGrip Your dose counter will be set at The dose counter will read 0 and the lever will not reach the end of the purple arrows whenthere are no doses remaining. 00000000 Pouch opened:Discard 1 month after removal from the foil pouch. ropionate and 100/ 60 60 doses left 9 doses left doses00000000 Pouch opened:Discard 1 month after removal from the foil pouch. propionate and 100/ 9 0 doses left 00000000Rx only the foil pouch. sone nate and erol inhalation powder, USP) /50 0 •WIXELA INHUB contains salmeterol, the same medicine found in SEREVENTproblems. WIXELA INHUB contains an ICS and a LABA. When an ICS and LABA are used together, there is not a to treat sudden breathing problems from asthma or COPD. Do not useto any of the ingredients in the products. Ask your healthcare provider if you are not sure.with other medicines that contain a LABA for any reason.Tell your healthcare provider about all the medicines you take and about all of your health conditions. upper respiratory tract infection, throat irritation,hoarseness and voice changes, thrush in your mouth or throat, bronchitis, cough, headache, and nausea and vomiting. Inthrush in your mouth or throat, throat irritation, hoarsenessand voice changes, viral respiratory infections, headache, and muscle and bone pain.Click Here for full Prescribing Information and Patient Information for full Instructions For Use. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit call 1-800-FDA-1088. For more information and to watch the How to Use video, visit WIXELA and INHUB are registered trademarks of Mylan Pharmaceuticals Inc., a Viatris Company

2 .ADVAIR DISKUS and SEREVENT are register
.ADVAIR DISKUS and SEREVENT are registered trademarks of the GSK group of companies. When using yourWixela® Inhub®please be aware of these important components MouthpieceDose counterMouthpiece coverYellow leverAir ventsGrip Your dose counter will be set at The dose counter will read 0 and the lever will not reach the end of the purple arrows whenthere are no doses remaining. 00000000 Pouch opened:Discard 1 month after removal from the foil pouch. ropionate and 100/ 60 60 doses left 9 doses left doses00000000 Pouch opened:Discard 1 month after removal from the foil pouch. propionate and 100/ 9 0 doses left 00000000Rx only the foil pouch. sone nate and erol inhalation powder, USP) /50 0 •WIXELA INHUB contains salmeterol, the same medicine found in SEREVENTLABA medicines such as salmeterol when used alone increase the risk of hospitalizations and death from asthmaproblems. WIXELA INHUB contains an ICS and a LABA. When an ICS and LABA are used together, there is not ato treat sudden breathing problems from asthma or COPD. Do not useto any of the ingredients in the products. Ask your healthcare provider if you are not sure.with other medicines that contain a LABA for any reason.Tell your healthcare provider about all the medicines you take and about all of your health conditions. upper respiratory tract infection, throat irritation,hoarseness and voice changes, thrush in your mouth or throat, bronchitis, cough, headache, and nausea and vomiting. Inthrush in your mouth or throat, throat irritation, hoarsenessand voice changes, viral respiratory infections, headache, and muscle and bone pain.Click Here for full Prescribing Information and Patient Information for full Instructions For Use. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit call 1-800-FDA-1088. For more information and to watch the How to Use video, visit HOW TO USE WIXELA® INHUB®Wixela Inhubwas designed with patients in mind to help you make a seamless transition from ADVAIR DISKUS® (uticasone propionate and salmeterol inhalation powder).Take Wixela Inhub out of the foil pouch just before you use it for the rst time. Write the “Pouch opened” and “Use by” dates oThe “Use by” date is one month from the date you open the pouch for your rst dose. Follow the 5 steps below each time you take a dose. 1 •Hold the INHUB in the •The INHUB is now ready to use. 4 doses00000000 Discard 1 month after propionate and do0000000Rxly ou openeUse Disc montaftovaro tefoi MDR:9320:60D:R-A78-9320-3 uicasoneropionate ansalmeterol inhalation powder, USP 100/ •Push the mouthpiece cover up to the closed•The dose counter will count down one dose as•The INHUB is now ready for you to take your doses0000000 Pouchopened:Use by:Discar 1 month afterremoval from the foil pouch. A-2R:D06:0239:RDMNDC0378--32 propionate and 50 •Before you breathe in your dose from the INHUB, breathe out (exhale) as long as you•Put the mouthpiece to your lips. Breathe in quickly and deeply through the INHUB.•Remove the INHUB from your mouth •The INHUB delivers your dose of medicine as a very fine powder that you may or may not taste WIXELA INHUB is a twice-daily prescription medicine used to control symptoms of asthma and to prevent symptoms such as wheezing in patients 4 years and older. WIXELA INHUB is for adults and children with asthma who are not well controlled with an asthma control medicine, such as an inhaled corticosteroid (ICS) medicine and need both an ICS and long-acting betaWIXELA INHUB 250/50 is a twice-daily prescription medicine used long term to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis, emphysema, or both, for better breathing and fewer flare-ups. Patient Information for full Instructions for Use.